Vande Casteele, Niels

Niels Vande Casteele

Assistant Professor, Department of Medicine, School of Medicine
Affiliate Faculty, Skaggs School of Pharmacy & Pharmaceutical Sciences
University of California San Diego
La Jolla, California USA

Dr. Vande Casteele holds a Bachelor in Pharmaceutical Sciences and Master in Drug Design and Development from the University of Leuven, Belgium. He performed research in the field of Molecular Biology at the Institute of Medical Sciences, University of Aberdeen, Scotland and in the field of Immunology at Sanquin, University of Amsterdam, the Netherlands. He obtained his Ph.D. in Pharmaceutical Sciences entitled “Optimizing anti-TNF therapy in inflammatory bowel disease patients, a step towards personalized dosing” at the University of Leuven, Belgium.

Dr. Vande Casteele currently holds an appointment as Assistant Professor of Medicine at the University of California San Diego, United States, where he teaches a course on Biologics and Biosimilars Drug Development. Dr. Vande Casteele also holds a position of Director, Precision Medicine at Alimentiv, Inc. where he oversees the Clinical Pharmacology and Translational Research program that focuses on the development, validation and implementation of clinical and translational research tools to ascertain efficient (early) drug development in sponsor- and investigator-initiated studies. His main research efforts focus on clinical pharmacology and translational medicine of small and large molecules used in the treatment of chronic inflammatory diseases, with an emphasis on characterizing pharmacokinetics and pharmacodynamics in relation to treatment outcomes in clinical practice and drug development.

Dr. Vande Casteele has published over 100 peer reviewed research articles and book chapters, he has given over 30 invited lectures, and he has received awards for his research contributions from distinguished professional organizations such as the European Crohn’s and Colitis Organization (ECCO), the American Gastroenterological Association (AGA), the Crohn’s and Colitis Foundation (CCF) and United European Gastroenterology (UEG) association.